133 related articles for article (PubMed ID: 7734364)
1. Effective treatment of disease-related anaemia in B-chronic lymphocytic leukaemia patients with recombinant human erythropoietin.
Pangalis GA; Poziopoulos C; Angelopoulou MK; Siakantaris MP; Panayiotidis P
Br J Haematol; 1995 Mar; 89(3):627-9. PubMed ID: 7734364
[TBL] [Abstract][Full Text] [Related]
2. Correction of disease related anaemia of B-chronic lymphoproliferative disorders by recombinant human erythropoietin: maintenance is necessary to sustain response.
Siakantaris MP; Angelopoulou MK; Vassilakopoulos TP; Dimopoulou MN; Kontopidou FN; Pangalis GA
Leuk Lymphoma; 2000 Dec; 40(1-2):141-7. PubMed ID: 11426615
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
5. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
Marques da Costa R
Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
[TBL] [Abstract][Full Text] [Related]
6. Downstaging Rai stage III B-chronic lymphocytic leukemia patients with the administration of recombinant human erythropoietin.
Pangalis GA; Siakantaris MP; Angelopoulou MK; Vassilakopoulos TP; Dimopoulou MN; Kyrtsonis MC; Konstantopoulos K; Tsaftaridis P; Vaiopoulos GA; Kontopidou FN
Haematologica; 2002 May; 87(5):500-6. PubMed ID: 12010663
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin in the treatment of the anaemia of cancer.
Abels RI
Acta Haematol; 1992; 87 Suppl 1():4-11. PubMed ID: 1574966
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
[TBL] [Abstract][Full Text] [Related]
9. The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS).
Rose EH; Abels RI; Nelson RA; McCullough DM; Lessin L
Br J Haematol; 1995 Apr; 89(4):831-7. PubMed ID: 7772519
[TBL] [Abstract][Full Text] [Related]
10. Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial.
Stone WJ; Graber SE; Krantz SB; Dessypris EN; O'Neil VL; Olsen NJ; Pincus TP
Am J Med Sci; 1988 Sep; 296(3):171-9. PubMed ID: 3177433
[TBL] [Abstract][Full Text] [Related]
11. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer.
Abels RI
Semin Oncol; 1992 Jun; 19(3 Suppl 8):29-35. PubMed ID: 1615337
[TBL] [Abstract][Full Text] [Related]
12. The future of r-HuEPO.
Eschbach JW
Nephrol Dial Transplant; 1995; 10 Suppl 2():96-109. PubMed ID: 7644114
[TBL] [Abstract][Full Text] [Related]
13. [Numerical and functional alterations in T and B lymphocyte subpopulations in CAPD patients treated with recombinant human erythropoietin].
Tanabe R
Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1159-68. PubMed ID: 7815748
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin and the anaemia of chronic disease.
Krantz SB
Nephrol Dial Transplant; 1995; 10 Suppl 2():10-7. PubMed ID: 7644100
[TBL] [Abstract][Full Text] [Related]
16. Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan.
Akizawa T; Koshikawa S; Takaku F; Urabe A; Akiyama N; Mimura N; Otsubo O; Nihei H; Suzuki Y; Kawaguchi Y
Int J Artif Organs; 1988 Sep; 11(5):343-50. PubMed ID: 3056862
[TBL] [Abstract][Full Text] [Related]
17. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.
Sweeney PJ; Nicolae D; Ignacio L; Chen L; Roach M; Wara W; Marcus KC; Vijayakumar S
Br J Cancer; 1998 Jun; 77(11):1996-2002. PubMed ID: 9667681
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
Frenken LA; Verberckmoes R; Michielsen P; Koene RA
Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin and chronic lymphocytic leukemia.
Mauro FR; Gentile M; Foa R
Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]